GlassScriptPhysician profile
Lorna Baer
NPI 1801340823
$1,680.80
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $937 · 2022: $59.94 · 2023: $340 · 2024: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $571.00 | 2021-2024 | |
| Merz North America, INC. | $179.06 | 2024 | |
| Janssen Biotech, INC. | $158.69 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $138.93 | 2021 | |
| Nestle Healthcare Nutrition INC. | $114.07 | 2021 | |
| Merck Sharp & Dohme LLC | $85.01 | 2021-2023 | Dificid |
| Astrazeneca Pharmaceuticals LP | $52.30 | 2021 | |
| Ironwood Pharmaceuticals, INC | $50.24 | 2023 | Linzess |
| Si-Bone, INC. | $43.54 | 2024 | |
| Braintree Laboratories, INC. | $40.10 | 2021-2023 | Sutab |
| Axonics, INC. | $33.14 | 2024 | Axonics |
| Celgene Corporation | $30.13 | 2021-2023 | Zeposia |
| Phathom Pharmaceuticals, INC. | $29.23 | 2024 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.27 | 2021-2022 | |
| Gilead Sciences, INC. | $25.43 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $24.90 | 2021 | |
| Collegium Pharmaceutical, INC. | $24.42 | 2023 | Xtampza |
| Qol Medical, LLC | $19.73 | 2021 | |
| Boston Scientific Corporation | $17.74 | 2021 | |
| Redhill Biopharma INC. | $15.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorna Baer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.